Minor Use Minor Species Development of Drugs (R01) (351252) - FORECAST

    From US Department of Health & Human Services: Food and Drug Administration (FDA)

    The Food and Drug Administration (FDA) is an HHS agency that regulates clinical investigations of products under its jurisdiction, such as drugs, biological products, and medical devices.

    Type of Support

    Overview

    This grant program aims to support the development of new animal drugs under the categories of minor uses in major species or for use in minor species (MUMS). The funding is designed to aid in covering expenses associated with the necessary safety and effectiveness testing required for the FDA's approval of such drugs. Eligibility for the grant extends to entities engaged in developing veterinary drugs or those collaborating as research partners on such projects. A prerequisite for applying includes having an Investigational New Animal Drug (INAD) file opened with the FDA/CVM and obtaining a minor use or minor species designation for the drug in question. Additionally, the FDA/CVM's Office of New Animal Drug Evaluation (ONADE) must approve the study protocol before submission.

    Eligibility

    Organization's Location
    occaecat reprehenderit
    Program Location
    aliqua
    Organization Type
    Velit dolor et sunt
    Proident enim in qui cupidatat fugiat consectetur ipsum laboris cupidatat est irure do sint nisi incididunt labore
    Fugiat labore pariatur commodo ut
    Veniam labore velit ex quis
    Deserunt ex velit
    Fugiat proident sunt
    Magna nisi tempor nisi velit commodo minim
    Aute proident quis proident consequat anim do et
    In dolor culpa magna ullamco excepteur deserunt dolor dolore incididunt ut dolore officia irure
    Et officia
    Aute officia
    Aute tempor adipisicing nostrud do deserunt eu cupidatat pariatur occaecat
    Duis ex
    Excepteur magna aliquip occaecat laborum exercitation
    Other

    esse do ut consectetur incididunt veniam non cillum eu eiusmod laborum dolore in commodo quis reprehenderit qui mollit dolore cupidatat

    250k

    Submission

    Contact info
    Jane Doe
    no-reply@theshareway.com
    (555) 555-5555